Table 1.
Demographic and clinical characteristics of healthy controls and patients included in the study.
| Healthy controls | Patients with AD | P | |||
|---|---|---|---|---|---|
| All | Standard treatment | Standard treatment + DBB | |||
| n | 14 | 28* | 14* | 14* | |
| Female gender | 5 (35.7%) | 16 (57.1%) | 7 (53.8%) | 8 (66.6%) | 0.64 |
| Age in years, median (range) | 10 (5-16) | 11.5 (5-15) | 12 (5-15) | 11 (6-13) | 0.14 |
| Years since AD diagnosis, median (range) | 3 (1-14) | 3 (0-14) | 2 (1-13) | ||
| Baseline SCORAD, median (range) | 45.10 (25.8-85.6) | 46.85 (26.5-84) | 44.1 (25.8-85.6) | 0.47 | |
| Visit 2 SCORAD, median (range) | 25.05 (4.3-76.2) | 25.7 (8.2-76.2) | 22.8 (4.3-68.7) | 0.85 | |
| n=26 | n=13 | n=13 | |||
| Visit 3 SCORAD, median (range) | 22.9 (1-70.9) | 26.70 (8.6-70.9) | 17.1 (1-58.4) | 0.12 | |
| n=24 | n=11 | n=13 | |||
| Visit 4 SCORAD, median (range) | 15.90 (0-75.7) | 17.9 (3.5-75.7) | 15.3 (0-66.6) | 0.7 | |
| n=21 | n=10 | n=11 | |||
*Number of patients at the beginning of the study; AD, atopic dermatitis; DBB, dilute bleach baths.